Poseida taps former Novartis VP as president of gene therapy
Poseida Therapeutics has hired former Novartis Vice Presiden
Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poseida Therapeutics has hired former Novartis Vice Presiden
The Paws at Play program at St. Jude Children's Research Hospital plays a very important part in helping families cope with their child's diagnosis. They are trained as service dogs that distract patients from their symptoms, illness, pain, and anxiety. They are there to motivate and support too with social interaction.
The shock waves caused by the success of AstraZeneca’s TOPAZ-1 clinical trial have reached Norway. After reviewing the results, PCI Biotech has decided to scrap its own pivotal advanced biliary tract cancer trial in the belief it may struggle to complete the study and win approval.
Moderna is doling out a little bit of its COVID-19 vaccine cash in a $45 million oncology research deal with Carisma Therapeutics to develop up to a dozen targets.
Sotio Biotech has advanced its effort to become a major player in the solid tumor space. Days after raising $316 million, Sotio has unveiled a deal with Merck to use Keytruda in a clinical trial that is central to its plans for investing in the megaround.